Long-term treatment of hyper fibrinogenenia in patients with cardiovascular risk factors

Witte, S.S.WitteAnadere, I.I.AnadereWalitza, E.E.Walitza2022-03-032022-03-031991https://publica.fraunhofer.de/handle/publica/180195enfibrinogenGingko bilobaplasma viscositywhole blood viscoelasticity610620660616Long-term treatment of hyper fibrinogenenia in patients with cardiovascular risk factorsjournal article